UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE TO
(Rule 13e-4)
TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1)
OF THE SECURITIES EXCHANGE ACT OF 1934
BOSTON SCIENTIFIC CORPORATION
(Name Of Subject Company (Issuer) Name of Filing Person (Offeror))
Common Stock, Par Value $0.01 Per Share
(Title of Class of Securities)
10113707
(CUSIP Number of Class of Securities)
Lawrence J. Knopf, Esq.
Boston Scientific Corporation
One Boston Scientific Place
Natick, MA 01760-1537
(Name, address, and telephone number of person authorized to receive notices
and communications on behalf of filing persons)
CALCULATION OF FILING FEE
|
|
|
Transaction Valuation* |
|
Amount of Filing fee* |
Not applicable
|
|
Not applicable |
|
|
|
* |
|
No filing fee is required because this filing contains only
preliminary communications made before the commencement of a tender
offer. |
|
¨ |
|
Check the box if any part of the fee is offset as provided by
Rule 0-11(a)(2) and identify the filing with which the
offsetting fee was previously paid. Identify the previous
filing by registration statement number, or the Form or
Schedule and the date of its filing. |
|
|
|
|
|
|
|
Amount Previously Paid: Not applicable
Form or Registration No.: Not applicable
|
|
Filing Party: Not applicable
Date Filed: Not applicable |
|
|
|
þ |
|
Check the box if the filing relates solely to preliminary
communications made before the commencement of a tender
offer. |
Check the appropriate boxes below to designate any transactions to which the statement
relates:
|
|
|
¨ |
|
third-party tender offer subject to Rule 14d-1. |
|
|
|
þ |
|
issuer tender offer subject to Rule 13e-4. |
|
|
|
¨ |
|
going-private transaction subject to Rule 13e-3. |
|
|
|
¨ |
|
amendment to Schedule 13D under Rule 13d-2. |
Check the following box if the filing is a final amendment reporting the results of the tender
offer: ¨
Form of Response E-mail
|
|
|
TO:
|
|
Boston Scientific Employee |
|
|
|
FROM:
|
|
BSC Equity Compensation Support |
Thank you for your question. We are in the process of gathering questions like yours and are
preparing responses to them. We intend to answer these questions at our informational sessions to
be conducted by webinar on the following dates: May 30th, May 31, June 12 and June 13th specific
times and information to follow. Please be sure to attend one of these session during which we
will make every effort to address your question.
This memo does not constitute an offer to sell or the solicitation of an offer to buy your
securities. The option exchange will involve a formal tender offer for your options. Anyone to whom
the tender offer is directed will be notified when the tender offer commences. We will deliver the
actual tender offer documents to all affected option holders when the tender offer commences, and
those documents will also be available for free at the SECs website.